facebook tracking

Metastatic Breast Cancer Patient Webinar Header

Free Patient Webinar

Know What Your Doctors Know: Metastatic Breast Cancer

Two chances to attend!

Thursday, October 8 4:00 – 5:15 PM EDT

register bc 2020

Monday, October 12 12:00 – 1:15 PM EDT

register bc 2020

Join experts as they discuss treatment of Metastatic Breast Cancer.

This webinar is designed to help participants:

  • Understand metastatic breast cancer
  • Compare, discuss, and select treatment options with their doctor

Each webinar will include a Question & Answer session. You may submit questions to the presenters during the webinar or in advance. Register for more details.


  • Introduction
  • Expert Discussion of Metastatic Breast Cancer
  • Question & Answer Session


  • John H. Ward, MD

    Margaret A. Amundsen Professor of Medicine
    Huntsman Cancer Institute at the University of Utah

  • Allison McManamon, RN, BSN

    Certified Breast Care Nurse (CBCN)
    Huntsman Cancer Institute at the University of Utah

  • Mary Lou Smith, MBA, JD

    Patient Advocate
    Research Advocacy Network

Intended Audience

This webinar is designed for those with metastatic breast cancer, caregivers, and families. Please note: This is a non-accredited activity.

Fee Information

Webinars are free to attend. A free copy of the NCCN Guidelines for Patients®: Metastatic Breast Cancer, Version 2020 will be sent to the first 500 registrants to request a book. Please provide your mailing address during registration to obtain your free book in the mail. We regret that we cannot send free print copies outside of the United States.


This webinar is supported through the NCCN Foundation®, by a contribution from our industry supporter AstraZeneca.

NCCN Foundation gratefully acknowledges the following corporate supporters for helping to make available these NCCN Guidelines for Patients: AstraZeneca, Lilly USA, LLC; Novartis Pharmaceutical Corporation; and Pfizer Inc. These NCCN Guidelines for Patients are also supported by an educational grant by Daiichi Sankyo and supported by a grant from Genentech, a member of the Roche Group. NCCN independently adapts, updates and hosts the NCCN Guidelines for Patients. Our corporate supporters do not participate in the development of the NCCN Guidelines for Patients and are not responsible for the content and recommendations contained therein.